BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3754087)

  • 1. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
    Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
    Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
    Hyder DM; Schnitzer B
    Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells.
    Ree HJ; Teplitz C; Khan A
    Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
    Kadin ME; Muramoto L; Said J
    Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
    Swerdlow SH; Wright SA
    Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
    Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
    Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative marker study of large cell lymphoma, Hodgkin's disease, and true histiocytic lymphoma in paraffin-embedded tissue.
    Meis JM; Osborne BM; Butler JJ
    Am J Clin Pathol; 1986 Nov; 86(5):591-9. PubMed ID: 2946220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
    Hsu SM; Yang K; Jaffe ES
    Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
    Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
    J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2.
    Ree HJ; Neiman RS; Martin AW; Dallenbach F; Stein H
    Cancer; 1989 May; 63(10):2030-6. PubMed ID: 2564804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
    Wieczorek R; Buck D; Bindl J; Knowles DM
    Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.